The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Capps Scott B since 2008.
The trader's CIK number is 1409753.
At the time of the last reporting, Capps Scott B was the VP, Clinical Research of Cryolife Inc. (stock ticker symbol CRY).
Also see all insider trading activities at Cryolife Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | CRY | 0 | $0 | 8,366 | $178,555 | 10,000 | $99,700 |
| 2019 | CRY | 0 | $0 | 9,184 | $236,211 | 10,000 | $61,200 |
| 2018 | CRY | 0 | $0 | 6,332 | $215,921 | 39,665 | $207,666 |
| 2017 | CRY | 0 | $0 | 11,083 | $181,772 | 16,667 | $116,835 |
| 2016 | CRY | 0 | $0 | 15,000 | $154,500 | 15,000 | $72,450 |
| 2013 | CRY | 0 | $0 | 25,000 | $265,100 | 25,000 | $226,500 |
| 2008 | CRY | 0 | $0 | 0 | $0 | 11,750 | $25,850 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-15 | CRY | Option Ex | 10,000 | 9.97 | 99,700 |
| 2020-12-15 | CRY | Sale | 8,366 | 21.34 | 178,555 |
| 2019-11-26 | CRY | Sale | 7,184 | 24.93 | 179,111 |
| 2019-11-26 | CRY | Option Ex | 10,000 | 6.12 | 61,200 |
| 2019-05-31 | CRY | Sale | 2,000 | 28.55 | 57,100 |
| 2018-08-30 | CRY | Sale | 6,332 | 34.10 | 215,921 |
| 2018-08-30 | CRY | Option Ex | 8,332 | 5.67 | 47,242 |
| 2018-02-13 | CRY | Option Ex | 31,333 | 5.12 | 160,424 |
| 2017-02-22 | CRY | Sale | 11,083 | 16.40 | 181,772 |
| 2017-02-22 | CRY | Option Ex | 16,667 | 7.01 | 116,835 |
| 2016-02-19 | CRY | Sale | 15,000 | 10.30 | 154,500 |
| 2016-02-19 | CRY | Option Ex | 15,000 | 4.83 | 72,450 |
| 2013-11-27 | CRY | Option Ex | 25,000 | 9.06 | 226,500 |
| 2013-11-27 | CRY | Sale | 25,000 | 10.60 | 265,100 |
| 2008-02-28 | CRY | Option Ex | 11,750 | 2.20 | 25,850 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Capps Scott B (VP, Clinical Research of Cryolife Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.